Annual EBITDA:
-$196.60M-$55.19M(-39.03%)Summary
- As of today, NRIX annual EBITDA is -$196.60 million, with the most recent change of -$55.19 million (-39.03%) on November 30, 2024.
- During the last 3 years, NRIX annual EBITDA has fallen by -$84.80 million (-75.84%).
- NRIX annual EBITDA is now -2812.15% below its all-time high of -$6.75 million, reached on November 30, 2018.
Performance
NRIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$43.23M+$15.51M(+26.41%)Summary
- As of today, NRIX quarterly EBITDA is -$43.23 million, with the most recent change of +$15.51 million (+26.41%) on May 31, 2025.
- Over the past year, NRIX quarterly EBITDA has increased by +$1.22 million (+2.75%).
- NRIX quarterly EBITDA is now -2048.36% below its all-time high of -$2.01 million, reached on August 31, 2019.
Performance
NRIX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$212.78M+$1.22M(+0.57%)Summary
- As of today, NRIX TTM EBITDA is -$212.78 million, with the most recent change of +$1.22 million (+0.57%) on May 31, 2025.
- Over the past year, NRIX TTM EBITDA has dropped by -$48.80 million (-29.76%).
- NRIX TTM EBITDA is now -9467.45% below its all-time high of -$2.22 million, reached on February 1, 2019.
Performance
NRIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NRIX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -39.0% | +2.8% | -29.8% |
| 3Y3 Years | -75.8% | -0.3% | -42.7% |
| 5Y5 Years | -888.8% | -239.4% | -277.2% |
NRIX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -75.8% | at low | -84.5% | +28.4% | -50.5% | +0.6% |
| 5Y | 5-Year | -888.8% | at low | -132.5% | +28.4% | -277.2% | +0.6% |
| All-Time | All-Time | -2812.2% | at low | -2048.4% | +28.4% | -9467.5% | +0.6% |
NRIX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2025 | - | -$43.23M(+26.4%) | -$212.78M(+0.6%) |
| Feb 2025 | - | -$58.74M(+2.7%) | -$214.00M(-8.9%) |
| Nov 2024 | -$196.60M(-39.0%) | -$60.35M(-19.6%) | -$196.60M(-10.6%) |
| Aug 2024 | - | -$50.47M(-13.5%) | -$177.82M(-8.4%) |
| May 2024 | - | -$44.45M(-7.5%) | -$163.99M(-14.7%) |
| Feb 2024 | - | -$41.33M(+0.6%) | -$142.97M(-1.1%) |
| Nov 2023 | -$141.41M(+18.3%) | -$41.58M(-13.5%) | -$141.41M(+2.8%) |
| Aug 2023 | - | -$36.63M(-56.3%) | -$145.49M(+4.7%) |
| May 2023 | - | -$23.43M(+41.1%) | -$152.69M(+11.4%) |
| Feb 2023 | - | -$39.77M(+12.9%) | -$172.34M(+0.4%) |
| Nov 2022 | -$173.06M | -$45.65M(-4.2%) | -$173.06M(-5.1%) |
| Aug 2022 | - | -$43.83M(-1.7%) | -$164.60M(-10.4%) |
| May 2022 | - | -$43.08M(-6.4%) | -$149.07M(-13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2022 | - | -$40.49M(-8.9%) | -$131.80M(-14.4%) |
| Nov 2021 | -$111.80M(-78.0%) | -$37.20M(-31.4%) | -$115.19M(-18.3%) |
| Aug 2021 | - | -$28.30M(-9.6%) | -$97.35M(-11.1%) |
| May 2021 | - | -$25.81M(-8.1%) | -$87.65M(-17.5%) |
| Feb 2021 | - | -$23.88M(-23.3%) | -$74.57M(-18.8%) |
| Nov 2020 | -$62.80M(-215.9%) | -$19.36M(-4.2%) | -$62.75M(-11.3%) |
| Aug 2020 | - | -$18.59M(-46.0%) | -$56.40M(-41.6%) |
| May 2020 | - | -$12.73M(-5.6%) | -$39.82M(-34.2%) |
| Feb 2020 | - | -$12.06M(+7.3%) | -$29.68M(-49.6%) |
| Nov 2019 | -$19.88M(-194.5%) | -$13.02M(-546.9%) | -$19.84M(-190.8%) |
| Aug 2019 | - | -$2.01M(+22.2%) | -$6.82M(-41.8%) |
| May 2019 | - | -$2.59M(-16.3%) | -$4.81M(-116.3%) |
| Feb 2019 | - | -$2.22M | -$2.22M |
| Nov 2018 | -$6.75M | - | - |
FAQ
- What is Nurix Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Nurix Therapeutics, Inc.?
- What is Nurix Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Nurix Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Nurix Therapeutics, Inc.?
- What is Nurix Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Nurix Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Nurix Therapeutics, Inc.?
- What is Nurix Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Nurix Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of NRIX is -$196.60M
What is the all-time high annual EBITDA for Nurix Therapeutics, Inc.?
Nurix Therapeutics, Inc. all-time high annual EBITDA is -$6.75M
What is Nurix Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, NRIX annual EBITDA has changed by -$55.19M (-39.03%)
What is Nurix Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of NRIX is -$43.23M
What is the all-time high quarterly EBITDA for Nurix Therapeutics, Inc.?
Nurix Therapeutics, Inc. all-time high quarterly EBITDA is -$2.01M
What is Nurix Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, NRIX quarterly EBITDA has changed by +$1.22M (+2.75%)
What is Nurix Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of NRIX is -$212.78M
What is the all-time high TTM EBITDA for Nurix Therapeutics, Inc.?
Nurix Therapeutics, Inc. all-time high TTM EBITDA is -$2.22M
What is Nurix Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, NRIX TTM EBITDA has changed by -$48.80M (-29.76%)